Clinical trial · Observational
Serum Exosomal Long Noncoding RNAs as Potential Biomarkers for Lung Cancer Diagnosis
NCT03830619CI-TRIAL-00055159completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The study is to investigate the sensitivity and specificity of serum exosome noncoding RNA as a biomarker for the diagnosis of lung cancer
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Cancer (Diagnosis) | Malignant Lung Neoplasm | CURATED_EXACT | 0.85 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| collect samples | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- lung cancer patients
- interventionNames
- Diagnostic Test: collect samples
- label
- normol volunteers
- interventionNames
- Diagnostic Test: collect samples
Primary outcomes (3)
- measure
- The expression levels of serum exosome long non-coding RNA
- timeFrame
- the first day subjects are enrolled the outcome will be assessed；up to three years after the completion of the study
- measure
- the expression levels of tumor biomarkers such as CEA, NSE, SCC, CYFR2A-1
- timeFrame
- the first day subjects are enrolled the outcome will be assessed；up to three years after the completion of the study
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: * Subjects are willing to sign the informed consent form; * Normal subjects have no evidence of any disease; * Lung cancer patients are 18 to 75 years old, diagnosed as lung cancer by histopathology or cytopathology Exclusion Criteria: * People are unwilling to sign the informed consent form; * Patients with heart disease, rheumatic disease, allergic disease, COPD, pulmonary fibrosis, diabetes, thyroid disease, liver, kidney, brain disease and hematopoietic system disease; * Pregnant or lactating women; * Patients did not cooperate or participate in other clinical trials
References
Publications (0)
Data not yet available
No reference posted for this study.